Roche presents new and updated data for Polivy in previously untreated diffuse large B-cell lymphoma at ASH 2022 December 12, 2022January 20, 2023 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: CHMP recommends EU approval of Roche’s Polivy…Roche’s Polivy combination approved by European…FDA accepts supplemental Biologics License…FDA Advisory Committee votes in favour of the…[Ad hoc announcement pursuant to Art. 53 LR] Phase…Roche’s Polivy combination reduced the risk of…Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)